{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 56,
        "end": 59
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 70,
        "end": 79
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 82,
        "end": 91
      }
    },
    {
      "id": "T4",
      "obj": "Disease",
      "span": {
        "begin": 129,
        "end": 135
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 141,
        "end": 149
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 56,
        "end": 69
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "24947927_1",
  "text": "Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 ( CH4987655 ) in selected patients with advanced cancer with RAS- RAF mutations ."
}
